Table 1. Adalimumab Injection Market Size & CAGR: China VS Global, 2019-2030, US$ Million

Table 2. Adalimumab Injection Market Restraints

Table 3. Adalimumab Injection Market Trends

Table 4. Adalimumab Injection Industry Policy

Table 5. Global Adalimumab Injection Revenue by Company, 2019-2023, US$ million

Table 6. Global Adalimumab Injection Revenue Market Share by Company, 2019-2023

Table 7. Global Adalimumab Injection Sales Volume by Company, 2019-2023, (K Units)

Table 8. Global Adalimumab Injection Sales Volume Market Share by Company, 2019-2023

Table 9. Global Adalimumab Injection Price by Company, 2019-2023, (US$/Unit)

Table 10. Global Adalimumab Injection Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Adalimumab Injection Mergers & Acquisitions, Expansion Plans

Table 12. Global Adalimumab Injection Manufacturers Product Type

Table 13. China Adalimumab Injection Revenue by Company, 2019-2023, US$ million

Table 14. China Adalimumab Injection Revenue Market Share by Company, 2019-2023

Table 15. China Adalimumab Injection Sales Volume by Company, 2019-2023, (K Units)

Table 16. China Adalimumab Injection Sales Volume Market Share by Company, 2019-2023

Table 17. China Market, Adalimumab Injection Production, Sales, Import and Export, 2019-2030, (K Units)

Table 18. China Adalimumab Injection Import & Export Trends

Table 19. Main Sources of China Adalimumab Injection Import

Table 20. Export Destination of China Adalimumab Injection

Table 21. Global Headquarters and Manufacturing Base of Adalimumab Injection Manufacturers

Table 22. Global Major Manufacturers, Adalimumab Injection Capacity Expansion and Future Plans

Table 23. Global Adalimumab Injection Production & Forecast by Region, 2019 VS 2023 VS 2030, (K Units)

Table 24. Global Adalimumab Injection Production by Region, 2019-2023, (K Units)

Table 25. Global Adalimumab Injection Production Forecast by Region, 2023-2030, (K Units)

Table 26. Global Key Players of Adalimumab Injection Upstream (Raw Materials)

Table 27. Global Adalimumab Injection Typical Customers

Table 28. Adalimumab Injection Typical Distributors

Table 29. By Type, Global Adalimumab Injection Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 30. By Application, Global Adalimumab Injection Revenue & CAGR, 2019 VS 2023 VS 2030, US$ Million

Table 31. By Region, Global Adalimumab Injection Market Size, 2019 VS 2023 VS 2030, US$ Million

Table 32. By Region, Global Adalimumab Injection Revenue, 2019-2030, US$ Million

Table 33. By Region, Global Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Table 34. By Country, Global Adalimumab Injection Revenue & CAGR，2019 VS 2023 VS 2030, US$ Million

Table 35. By Country, Global Adalimumab Injection Revenue, 2019-2030, US$ Million

Table 36. By Country, Global Adalimumab Injection Revenue Market Share, 2019-2030

Table 37. By Country, Global Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Table 38. By Country, Global Adalimumab Injection Sales Volume Market Share, 2019-2030

Table 39. AbbVie Company Information, Head Office, Market Area and Industry Position

Table 40. AbbVie Adalimumab Injection Models, Specifications and Application

Table 41. AbbVie Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 42. AbbVie Company Profile and Main Business

Table 43. AbbVie Recent Developments

Table 44. Amgen Company Information, Head Office, Market Area and Industry Position

Table 45. Amgen Adalimumab Injection Models, Specifications and Application

Table 46. Amgen Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 47. Amgen Company Profile and Main Business

Table 48. Amgen Recent Developments

Table 49. Sandoz Company Information, Head Office, Market Area and Industry Position

Table 50. Sandoz Adalimumab Injection Models, Specifications and Application

Table 51. Sandoz Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 52. Sandoz Company Profile and Main Business

Table 53. Sandoz Recent Developments

Table 54. Fresenius Kabi Company Information, Head Office, Market Area and Industry Position

Table 55. Fresenius Kabi Adalimumab Injection Models, Specifications and Application

Table 56. Fresenius Kabi Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 57. Fresenius Kabi Company Profile and Main Business

Table 58. Fresenius Kabi Recent Developments

Table 59. Biogen Company Information, Head Office, Market Area and Industry Position

Table 60. Biogen Adalimumab Injection Models, Specifications and Application

Table 61. Biogen Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 62. Biogen Company Profile and Main Business

Table 63. Biogen Recent Developments

Table 64. Celltrion Company Information, Head Office, Market Area and Industry Position

Table 65. Celltrion Adalimumab Injection Models, Specifications and Application

Table 66. Celltrion Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 67. Celltrion Company Profile and Main Business

Table 68. Celltrion Recent Developments

Table 69. Cadila Pharmaceuticals Company Information, Head Office, Market Area and Industry Position

Table 70. Cadila Pharmaceuticals Adalimumab Injection Models, Specifications and Application

Table 71. Cadila Pharmaceuticals Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 72. Cadila Pharmaceuticals Company Profile and Main Business

Table 73. Cadila Pharmaceuticals Recent Developments

Table 74. Bio-Thera Solutions, Ltd. Company Information, Head Office, Market Area and Industry Position

Table 75. Bio-Thera Solutions, Ltd. Adalimumab Injection Models, Specifications and Application

Table 76. Bio-Thera Solutions, Ltd. Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 77. Bio-Thera Solutions, Ltd. Company Profile and Main Business

Table 78. Bio-Thera Solutions, Ltd. Recent Developments

Table 79. Hisun Biopharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 80. Hisun Biopharmaceutical Adalimumab Injection Models, Specifications and Application

Table 81. Hisun Biopharmaceutical Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 82. Hisun Biopharmaceutical Company Profile and Main Business

Table 83. Hisun Biopharmaceutical Recent Developments

Table 84. Innovent Biologics Company Information, Head Office, Market Area and Industry Position

Table 85. Innovent Biologics Adalimumab Injection Models, Specifications and Application

Table 86. Innovent Biologics Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 87. Innovent Biologics Company Profile and Main Business

Table 88. Innovent Biologics Recent Developments

Table 89. Mylan Company Information, Head Office, Market Area and Industry Position

Table 90. Mylan Adalimumab Injection Models, Specifications and Application

Table 91. Mylan Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 92. Mylan Company Profile and Main Business

Table 93. Mylan Recent Developments

Table 94. Zydus Group Company Information, Head Office, Market Area and Industry Position

Table 95. Zydus Group Adalimumab Injection Models, Specifications and Application

Table 96. Zydus Group Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 97. Zydus Group Company Profile and Main Business

Table 98. Zydus Group Recent Developments

Table 99. Boehringer Ingelheim Company Information, Head Office, Market Area and Industry Position

Table 100. Boehringer Ingelheim Adalimumab Injection Models, Specifications and Application

Table 101. Boehringer Ingelheim Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 102. Boehringer Ingelheim Company Profile and Main Business

Table 103. Boehringer Ingelheim Recent Developments

Table 104. Jiangsu Chia Tai-Tianqing Pharmaceutical Company Information, Head Office, Market Area and Industry Position

Table 105. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Models, Specifications and Application

Table 106. Jiangsu Chia Tai-Tianqing Pharmaceutical Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 107. Jiangsu Chia Tai-Tianqing Pharmaceutical Company Profile and Main Business

Table 108. Jiangsu Chia Tai-Tianqing Pharmaceutical Recent Developments

Table 109. Shanghai Henlius Biotech Company Information, Head Office, Market Area and Industry Position

Table 110. Shanghai Henlius Biotech Adalimumab Injection Models, Specifications and Application

Table 111. Shanghai Henlius Biotech Adalimumab Injection Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2019-2023

Table 112. Shanghai Henlius Biotech Company Profile and Main Business

Table 113. Shanghai Henlius Biotech Recent Developments

List of Figure

Figure 1. Adalimumab Injection Picture

Figure 2. By Revenue, Global Adalimumab Injection Market Size and Forecast, 2019-2030, US$ Million

Figure 3. By Sales Volume, Global Adalimumab Injection Market Size and Forecast, 2019-2030, (K Units)

Figure 4. Global Adalimumab Injection Price Trend, 2019-2030, (US$/Unit)

Figure 5. By Revenue, China Adalimumab Injection Market Size and Forecast, 2019-2030, US$ million

Figure 6. By Sales Volume, China Adalimumab Injection Market Size and Forecast, 2019-2030, (K Units)

Figure 7. China Adalimumab Injection Price Trend, 2019-2030 (US$/Unit)

Figure 8. By Revenue, China Adalimumab Injection Share of Global Market, 2019-2030

Figure 9. By Sales Volume, China Adalimumab Injection Share of Global Market, 2019-2030

Figure 10. Global Adalimumab Injection Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 11. Global Adalimumab Injection Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2023

Figure 12. China Adalimumab Injection Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 13. China Adalimumab Injection Key Participants, Market Share, 2021 VS 2023 VS 2023

Figure 14. China Adalimumab Injection Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2019-2023

Figure 15. Chinese Local Players, Proportion of Adalimumab Injection Domestic VS Export, 2023

Figure 16. Global Adalimumab Injection Capacity, Production and Capacity Utilization, 2019-2030

Figure 17. Global Adalimumab Injection Capacity Market Share by Region, 2023 VS 2030

Figure 18. Global Adalimumab Injection Production Market Share & Forecast by Region, 2019-2030

Figure 19. Adalimumab Injection Industry Chain

Figure 20. Adalimumab Injection Procurement Model

Figure 21. Adalimumab Injection Sales Model

Figure 22. Adalimumab Injection Sales Channels, Direct Sales and Distribution

Figure 23. 40mg/0.8ml

Figure 24. 20mg/0.4ml

Figure 25. By Type, Global Adalimumab Injection Revenue, 2019-2030, US$ Million

Figure 26. By Type, Global Adalimumab Injection Revenue Market Share, 2019-2030

Figure 27. By Type, Global Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 28. By Type, Global Adalimumab Injection Sales Volume Market Share, 2019-2030

Figure 29. By Type, Global Adalimumab Injection Price, 2019-2030, (US$/Unit)

Figure 30. Hospitals

Figure 31. Clinics

Figure 32. Others

Figure 33. By Application, Global Adalimumab Injection Revenue, 2019-2030, US$ Million

Figure 34. By Application, Global Adalimumab Injection Revenue Market Share, 2019-2030

Figure 35. By Application, Global Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 36. By Application, Global Adalimumab Injection Sales Volume Market Share, 2019-2030

Figure 37. By Application, Global Adalimumab Injection Price, 2019-2030, (US$/Unit)

Figure 38. By Region, Global Adalimumab Injection Revenue Market Share, 2019-2030

Figure 39. By Region, Global Adalimumab Injection Sales Volume Market Share, 2019-2030

Figure 40. North America Adalimumab Injection Revenue & Forecasts, 2019-2030, US$ Million

Figure 41. By Country, North America Adalimumab Injection Revenue Market Share, 2023

Figure 42. Europe Adalimumab Injection Revenue & Forecasts, 2019-2030, US$ Million

Figure 43. By Country, Europe Adalimumab Injection Revenue Market Share, 2023

Figure 44. Asia Pacific Adalimumab Injection Revenue & Forecasts, 2019-2030, US$ Million

Figure 45. By Country/Region, Asia Pacific Adalimumab Injection Revenue Market Share, 2023

Figure 46. South America Adalimumab Injection Revenue & Forecasts, 2019-2030, US$ Million

Figure 47. By Country, South America Adalimumab Injection Revenue Market Share, 2023

Figure 48. Middle East & Africa Adalimumab Injection Revenue & Forecasts, 2019-2030, US$ Million

Figure 49. U.S. Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 50. By Company, U.S. Adalimumab Injection Market Share, 2023

Figure 51. By Type, U.S. Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 52. By Application, U.S. Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 53. Europe Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 54. By Company, Europe Adalimumab Injection Market Share, 2023

Figure 55. By Type, Europe Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 56. By Application, Europe Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 57. China Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 58. By Company, China Adalimumab Injection Market Share, 2023

Figure 59. By Type, China Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 60. By Application, China Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 61. Japan Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 62. By Company, Japan Adalimumab Injection Market Share, 2023

Figure 63. By Type, Japan Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 64. By Application, Japan Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 65. South Korea Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 66. By Company, South Korea Adalimumab Injection Market Share, 2023

Figure 67. By Type, South Korea Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 68. By Application, South Korea Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 69. Southeast Asia Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 70. By Company, Southeast Asia Adalimumab Injection Market Share, 2023

Figure 71. By Type, Southeast Asia Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 72. By Application, Southeast Asia Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 73. India Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 74. By Company, India Adalimumab Injection Market Share, 2023

Figure 75. By Type, India Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 76. By Application, India Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 77. Middle East & Asia Adalimumab Injection Sales Volume, 2019-2030, (K Units)

Figure 78. By Company, Middle East & Asia Adalimumab Injection Market Share, 2023

Figure 79. By Type, Middle East & Asia Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 80. By Application, Middle East & Asia Adalimumab Injection Sales Volume Market Share, 2023 VS 2030

Figure 81. Research Methodology

Figure 82. Breakdown of Primary Interviews

Figure 83. Bottom-up Approaches

Figure 84. Top-down Approaches